Immutep Limited Surges Beyond Resistance Level on Positive Updates
Immutep Limited (NASDAQ: IMMP), an Australian biotechnology company focused on developing immunotherapeutic products for cancer and autoimmune diseases, is experiencing a significant premarket price surge.